Vactosertib is under investigation in clinical trial NCT03724851 (Vactosertib in Combination With Pembrolizumab in Metastatic Colorectal or Gastric Cancer).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.